...
首页> 外文期刊>European review for medical and pharmacological sciences. >HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis
【24h】

HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis

机译:HuR,TTP和miR-133b在NSCLC中的表达及其与预后的关系

获取原文

摘要

OBJECTIVE: This study sought to explore HuR, Thrombotic Thrombocytopenic Purpura (TTP), and microRNA 133b (miR-133b) expression levels in non-small cell lung cancer (NSCLC) patients and assess the relationship of expression with disease prognosis. PATIENTS AND METHODS: One hundred and ten paraffin-embedded and 33 fresh flash-frozen NSCLC samples, together with matched tumor adjacent normal tissue controls, were collected from patients between January 2013 and July 2015 in Yidu Central Hospital of Weifang. Twenty-nine patients provided both paraffin-embedded and fresh frozen tissues. HuR and TTP protein expression levels were measured in 110 paraffin-embedded tumors and matched controls using immunohistochemistry, while miR-133b levels were measured using Real-time fluorescent quantitative PCR. RESULTS: Follow-up parameters included treatment response, relapse events, post-relapse treatment, disease free survival (DFS), and overall survival (OS). HuR expression was significantly different between tumor and matched controls (p < 0.0001). Cytoplasmic expression levels of HuR and TTP correlated with pTNM staging (p < 0.05). No significant correlation was observed between HuR and TTP expression and other clinical pathological factors (gender, age, tumor size, pathological subtype, differentiation status, lymph node metastasis, distant metastasis, and tumor invasiveness). MiR-133b expression correlated with tumor size (p = 0.015) and differentiation status (p = 0.013) in paraffin-embedded sections, but was only correlated with pTNM staging (p = 0.032) in frozen tissue samples. No significant difference in DFS nor OS was observed between 68 HuR-positive and 42 HuR-negative patients (DFS, Log Rank p = 0.712; OS, Log Rank p = 0.220). However, DFS and OS were significantly different between miR-133b high-expression and low-expression patients (DFS, Log Rank p = 0.048 < 0.05; OS, Log Rank p = 0.025 < 0.05). This indicates that miR-133b levels may have prognostic value. CONCLUSIONS: HuR expression was negatively correlated with TTP expression in NSCLC tissues. MiR-133b levels were downregulated in normal tissues compared to both paraffin and frozen tumor samples, and correlated with both HuR and TTP expression, which may affect the prognosis of NSCLC patients.
机译:目的:本研究旨在探讨非小细胞肺癌(NSCLC)患者的HuR,血栓性血小板减少性紫癜(TTP)和microRNA 133b(miR-133b)表达水平,并评估其与疾病预后的关系。患者与方法:2013年1月至2015年7月间,从潍坊市宜都市中心医院收治的110例石蜡包埋的和33例新鲜的速冻NSCLC样品,以及与肿瘤相匹配的正常组织对照。 29名患者提供了石蜡包埋的和新鲜的冷冻组织。使用免疫组织化学方法检测110例石蜡包埋的肿瘤和配对对照中的HuR和TTP蛋白表达水平,同时使用实时荧光定量PCR检测miR-133b水平。结果:随访参数包括治疗反应,复发事件,复发后治疗,无病生存期(DFS)和总生存期(OS)。在肿瘤和匹配的对照之间,HuR表达明显不同(p <0.0001)。 HuR和TTP的细胞质表达水平与pTNM分期相关(p <0.05)。在HuR和TTP表达与其他临床病理因素(性别,年龄,肿瘤大小,病理亚型,分化状态,淋巴结转移,远处转移和肿瘤浸润性)之间未观察到显着相关性。在石蜡包埋的切片中,MiR-133b表达与肿瘤大小(p = 0.015)和分化状态(p = 0.013)相关,但仅与冷冻组织样品中的pTNM分期(p = 0.032)相关。在68例HuR阳性和42例HuR阴性患者之间,DFS和OS均无显着差异(DFS,对数秩p = 0.712; OS,对数秩p = 0.220)。但是,高表达和低表达的miR-133b患者之间的DFS和OS显着不同(DFS,Log Rank p = 0.048 <0.05; OS,Log Rank p = 0.025 <0.05)。这表明miR-133b水平可能具有预后价值。结论:NSCLC组织中HuR的表达与TTP的表达呈负相关。与石蜡和冷冻肿瘤样品相比,正常组织中的MiR-133b水平下调,并且与HuR和TTP表达均相关,这可能会影响NSCLC患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号